SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-059849
Filing Date
2023-05-12
Accepted
2023-05-12 17:05:35
Documents
16
Period of Report
2023-05-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2315501d2_8k.htm   iXBRL 8-K 33787
2 EXHIBIT 1.1 tm2315501d2_ex1-1.htm EX-1.1 247003
3 EXHIBIT 5.1 tm2315501d2_ex5-1.htm EX-5.1 14526
7 GRAPHIC tm2315501d2_ex5-1img001.jpg GRAPHIC 3303
8 GRAPHIC tm2315501d2_ex5-1img002.jpg GRAPHIC 17503
  Complete submission text file 0001104659-23-059849.txt   565655

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA carm-20230512.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE carm-20230512_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE carm-20230512_pre.xml EX-101.PRE 22597
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2315501d2_8k_htm.xml XML 3606
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 23916893
SIC: 2834 Pharmaceutical Preparations